Thu, March 31, 2022

Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $9 on, Mar 31st, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-9-on-mar-31st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Brian Abrahams of RBC Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Hold with Decreased Target from $12 to $9 on, Mar 31st, 2022.

Brian has made no other calls on ATAI in the last 4 months.



There is 1 other peer that has a rating on ATAI. Out of the 1 peers that are also analyzing ATAI, 0 agree with Brian's Rating of Hold.



This is the rating of the analyst that currently disagrees with Brian


  • Michael Okunewitch of "Maxim Group" Initiated at Strong Buy and Held Target at $25 on, Tuesday, November 30th, 2021